帕金森病冻结步态的相关因素研究进展

doi:10.16138/j.1673-6087.2022.04.014

摘要/Abstract

关键词: 帕金森病, 冻结步态, 相关因素, 震颤, 运动障碍

中图分类号:

R593.2

王新新, 田敏, 张秀芳, 刘艺鸣. 帕金森病冻结步态的相关因素研究进展[J]. 内科理论与实践, 2022, 17(04): 339-343.

图/表 1

参考文献 46

[1]	Okuma Y, Silva de Lima AL, Fukae J, et al. A prospective study of falls in relation to freezing of gait and response fluctuations in Parkinson’s disease[J]. Parkinsonism Relat Disord, 2018, 46: 30-35. doi: 10.1016/j.parkreldis.2017.10.013 URL
[2]	Walton CC, Shine JM, Hall JM, et al. The major impact of freezing of gait on quality of life in Parkinson’s disease[J]. J Neurol, 2015, 262(1):108-115. doi: 10.1007/s00415-014-7524-3 URL
[3]	Giladi N, Nieuwboer A. Understanding and treating freezing of gait in Parkinsonism, proposed working definition, and setting the stage[J]. Mov Disord, 2008, 23 Suppl 2: S423-S425.
[4]	Schaafsma JD, Balash Y, Gurevich T, et al. Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson’s disease[J]. Eur J Neurol, 2003, 10(4): 391-398. pmid: 12823491
[5]	Zhang WS, Gao C, Tan YY, et al. Prevalence of freezing of gait in Parkinson’s disease: a systematic review and meta-analysis[J]. J Neurol, 2021, 268(11): 4138-4150. doi: 10.1007/s00415-021-10685-5 URL
[6]	Factor SA. The clinical spectrum of freezing of gait in atypical parkinsonism[J]. Mov Disord, 2008, 23 Suppl 2: S431-S438.
[7]	Nutt JG, Bloem BR, Giladi N, et al. Freezing of gait: moving forward on a mysterious clinical phenomenon[J]. Lancet Neurol, 2011, 10(8): 734-744. doi: 10.1016/S1474-4422(11)70143-0 URL
[8]	Cucca A, Biagioni MC, Fleisher JE, et al. Freezing of gait in Parkinson’s disease: from pathophysiology to emerging therapies[J]. Neurodegener Dis Manag, 2016, 6(5): 431-446. doi: 10.2217/nmt-2016-0018 URL
[9]	Kostic VS, Agosta F, Pievani M, et al. Pattern of brain tissue loss associated with freezing of gait in Parkinson disease[J]. Neurology, 2012, 78(6): 409-416. doi: 10.1212/WNL.0b013e318245d23c pmid: 22282641
[10]	Calabresi P, Picconi B, Parnetti L, et al. A convergent model for cognitive dysfunctions in Parkinson’s disease: the critical dopamine-acetylcholine synaptic balance[J]. Lancet Neurol, 2006, 5(11): 974-983. pmid: 17052664
[11]	Bartels AL, de Jong BM, Giladi N, et al. Striatal dopa and glucose metabolism in PD patients with freezing of gait[J]. Mov Disord, 2006, 21(9): 1326-1332. doi: 10.1002/mds.20952 URL
[12]	Brooks VB, Stoney SD Jr. Motor mechanisms: the role of the pyramidal system in motor control[J]. Annu Rev Physiol, 1971, 33: 337-392. pmid: 4951052
[13]	Plotnik M, Giladi N, Hausdorff JM. Is freezing of gait in Parkinson’s disease a result of multiple gait impairments? Implications for treatment[J]. Parkinsons Dis, 2012, 2012: 459321.
[14]	Lewis SJ, Barker RA. A pathophysiological model of freezing of gait in Parkinson’s disease[J]. Parkinsonism Relat Disord, 2009, 15(5): 333-338. doi: 10.1016/j.parkreldis.2008.08.006 URL
[15]	Vandenbossche J, Deroost N, Soetens E, et al. Freezing of gait in Parkinson’s disease: disturbances in automaticity and control[J]. Front Hum Neurosci, 2013, 6: 356.
[16]	Jacobs JV, Nutt JG, Carlson-Kuhta P, et al. Knee trembling during freezing of gait represents multiple anticipatory postural adjustments[J]. Exp Neurol, 2009, 215(2): 334-341. doi: 10.1016/j.expneurol.2008.10.019 pmid: 19061889
[17]	Macht M, Kaussner Y, Möller JC, et al. Predictors of freezing in Parkinson’s disease: a survey of 6,620 patients[J]. Mov Disord, 2007, 22(7): 953-956. doi: 10.1002/mds.21458 URL
[18]	Kim R, Lee J, Kim HJ, et al. CSF β-amyloid42 and risk of freezing of gait in early Parkinson disease[J]. Neurology, 2019, 92(1): e40-e47.
[19]	Djaldetti R, Rigbi A, Greenbaum L, et al. Can early dopamine transporter imaging serve as a predictor of Parkinson’s disease progression and late motor complications?[J]. J Neurol Sci, 2018, 390: 255-260. doi: S0022-510X(18)30220-X pmid: 29801899
[20]	Shulman LM. Is there a connection between estrogen and Parkinson’s disease?[J]. Parkinsonism Relat Disord, 2002, 8(5): 289-295. doi: 10.1016/S1353-8020(02)00014-7 URL
[21]	Ehgoetz Martens KA, Lukasik EL, Georgiades MJ, et al. Predicting the onset of freezing of gait: a longitudinal study[J]. Mov Disord, 2018, 33(1): 128-135. doi: 10.1002/mds.27208 URL
[22]	Zhang H, Yin X, Ouyang Z, et al. A prospective study of freezing of gait with early Parkinson disease in Chinese patients[J]. Medicine (Baltimore), 2016, 95(26): e4056.
[23]	Ortelli P, Ferrazzoli D, Cian V, et al. How Cognition and motivation “freeze” the motor behavior in Parkinson’s disease[J]. Front Neurosci, 2019, 13: 1302. doi: 10.3389/fnins.2019.01302 URL
[24]	Contreras A, Grandas F. Risk factors for freezing of gait in Parkinson’s disease[J]. J Neurol Sci, 2012, 320(1-2):66-71. doi: 10.1016/j.jns.2012.06.018 pmid: 22795382
[25]	Perez-Lloret S, Negre-Pages L, Damier P, et al. Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease[J]. JAMA Neurol, 2014, 71(7): 884-890. doi: 10.1001/jamaneurol.2014.753 pmid: 24839938
[26]	Ou R, Wei Q, Cao B, et al. Predictors of freezing of gait in Chinese patients with Parkinson’s disease[J]. Brain Behav, 2018, 8(3): e00931.
[27]	Herman T, Shema-Shiratzky S, Arie L, et al. Depressive symptoms may increase the risk of the future development of freezing of gait in patients with Parkinson’s disease: findings from a 5-year prospective study[J]. Parkinsonism Relat Disord, 2019, 60: 98-104. doi: 10.1016/j.parkreldis.2018.09.013 URL
[28]	Banks SJ, Bayram E, Shan G, et al. Non-motor predictors of freezing of gait in Parkinson’s disease[J]. Gait Posture, 2019, 68: 311-316. doi: 10.1016/j.gaitpost.2018.12.009 URL
[29]	Tan DM, McGinley JL, Danoudis ME, et al. Freezing of gait and activity limitations in people with Parkinson’s disease[J]. Arch Phys Med Rehabil, 2011, 92(7): 1159-1165. doi: 10.1016/j.apmr.2011.02.003 URL
[30]	Ge HL, Chen XY, Lin YX, et al. The prevalence of freezing of gait in Parkinson’s disease and in patients with different disease durations and severities[J]. Chin Neurosurg J, 2020, 6: 17. doi: 10.1186/s41016-020-00197-y URL
[31]	Kim R, Lee J, Kim HJ, et al. CSF β-amyloid 42 and risk of freezing of gait in early Parkinson disease[J]. Neurology, 2019, 92(1): e40-e47.
[32]	Kim R, Lee J, Kim Y, et al. Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson’s disease[J]. Parkinsonism Relat Disord, 2018, 51: 49-54. doi: 10.1016/j.parkreldis.2018.02.047 URL
[33]	Forsaa EB, Larsen JP, Wentzel-Larsen T, et al. A 12-year population-based study of freezing of gait in Parkinson’s disease[J]. Parkinsonism Relat Disord, 2015, 21(3): 254-258. doi: 10.1016/j.parkreldis.2014.12.020 URL
[34]	Zhang F, Shi J, Duan Y, et al. Clinical features and related factors of freezing of gait in patients with Parkinson’s disease[J]. Brain Behav, 2021, 11(11): e2359.
[35]	Magrinelli F, Picelli A, Tocco P, et al. Pathophysiology of motor dysfunction in Parkinson’s disease as the rationale for drug treatment and rehabilitation[J]. Parkinsons Dis, 2016, 2016: 9832839.
[36]	Schlenstedt C, Muthuraman M, Witt K, et al. Postural control and freezing of gait in Parkinson’s disease[J]. Parkinsonism Relat Disord, 2016, 24: 107-112. doi: 10.1016/j.parkreldis.2015.12.011 URL
[37]	Ou R, Guo X, Song W, et al. Freezing of gait in Chinese patients with Parkinson disease[J]. J Neurol Sci, 2014, 345(1-2): 56-60. doi: 10.1016/j.jns.2014.07.002 URL
[38]	Amboni M, Cozzolino A, Longo K, et al. Freezing of gait and executive functions in patients with Parkinson’s disease[J]. Mov Disord, 2008, 23(3): 395-400. doi: 10.1002/mds.21850 URL
[39]	Amboni M, Barone P, Picillo M, et al. A two-year follow-up study of executive dysfunctions in Parkinsonian patients with freezing of gait at on-state[J]. Mov Disord, 2010, 25(6): 800-802. doi: 10.1002/mds.23033 URL
[40]	Nantel J, McDonald JC, Tan S, et al. Deficits in visuospatial processing contribute to quantitative measures of freezing of gait in Parkinson’s disease[J]. Neuroscience, 2012, 221: 151-156. doi: 10.1016/j.neuroscience.2012.07.007 pmid: 22796080
[41]	Tang X, Yu L, Yang J, et al. Association of sleep disturbance and freezing of gait in Parkinson disease: prevention/delay implications[J]. J Clin Sleep Med, 2021, 17(4): 779-789. doi: 10.5664/jcsm.9022 URL
[42]	Romenets SR, Gagnon JF, Latreille V, et al. Rapid eye movement sleep behavior disorder and subtypes of Parkinson’s disease[J]. Mov Disord, 2012 Jul, 27(8): 996-1003. doi: 10.1002/mds.25086 URL
[43]	丁园, 祖洁, 董丽果, 等. 帕金森病冻结步态的临床特点及相关影响因素[J]. 临床神经病学杂志, 2019, 32(2): 118-121.
[44]	Alibiglou L, Videnovic A, Planetta PJ, et al. Subliminal gait initiation deficits in rapid eye movement sleep behavior disorder: a harbinger of freezing of gait?[J]. Mov Disord, 2016, 31(11): 1711-1719. doi: 10.1002/mds.26665 URL
[45]	Benninger DH, Michel J, Waldvogel D, et al. REM sleep behavior disorder is not linked to postural instability and gait dysfunction in Parkinson[J]. Mov Disord, 2010, 25(11): 1597-1604. doi: 10.1002/mds.23121 URL
[46]	Giladi N, Treves TA, Simon ES, et al. Freezing of gait in patients with advanced Parkinson’s disease[J]. J Neural Transm (Vienna), 2001, 108(1): 53-61.

类型	名称	与PD伴FOG相关性
人口学因素	性别	FOG发生率男性>女性
	年龄/发病年龄	暂无定论
	教育水平	暂无定论
病程与分期	病程	病程越长,FOG发生率越高
	H&Y分期	分期越高,FOG发生率越高
运动症状	临床分型与起病部位	PIGD型、下肢起病者更易发生FOG
	异常步态/跌倒/平衡障碍	FOG发生率增加
	运动波动	FOG发生率增加
非运动症状	焦虑与抑郁	FOG发生率增加
	认知功能减退	FOG发生率增加
	睡眠	暂无定论
抗PD药物	左旋多巴	FOG发生率增加
	多巴胺受体激动剂	暂无定论

帕金森病冻结步态的相关因素研究进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 1

参考文献 46

相关文章 15

编辑推荐

Metrics

本文评价

[1]	赵雅洁, 于晓璇, 王晓平. 第七届国际帕金森病暨运动障碍学术研讨会（上海）会议纪要[J]. 内科理论与实践, 2022, 17(05): 423-424.
[2]	董正椽, 王刚. 帕金森病患者照料者心理弹性水平及影响因素[J]. 内科理论与实践, 2021, 16(05): 325-330.
[3]	王晓平, 吴亦影. 试谈肝豆状核变性的几个历史典故[J]. 内科理论与实践, 2021, 16(05): 359-360.
[4]	李建平, 王刚. 铜代谢稳态失调与神经退行性疾病的相关性研究进展[J]. 内科理论与实践, 2021, 16(05): 361-365.
[5]	陈施吾, 窦荣花, 王玉凯, 王含, 王晓平, 陈先文, 陈玲, 王训, 屈洪党, 陈生弟, Susan Fox, 李燕, 王刚. 帕金森病血压管理专家共识[J]. 诊断学理论与实践, 2020, 19(05): 460-468.
[6]	邵丹丹, 付洋, 罗琪, 陈捷, 马建芳, 黄雷. 血清尿酸水平与帕金森病发病间关系的前瞻性研究[J]. 诊断学理论与实践, 2020, 19(02): 139-144.
[7]	热依沙·塔西买买提, 王晓平,. 第十三届世界神经病学争议大会纪要[J]. 内科理论与实践, 2019, 14(05): 328-330.
[8]	朱红灿, 张新凯, 李莉,. 左旋多巴诱导的异动症临床特点与药物治疗的反思和展望[J]. 内科理论与实践, 2019, 14(05): 276-281.
[9]	吴颖燕, 姚谦, 程琦,. 早期帕金森病生物标志物的研究进展[J]. 内科理论与实践, 2019, 14(04): 259-264.
[10]	武冬冬, 刘银红, 蒋景文, 陈海波. 放射性核素在帕金森病诊断中的应用[J]. 诊断学理论与实践, 2018, 17(06): 726-730.
[11]	王书鸿, 王晓平,. 第十二届国际神经病学辩论大会纪要[J]. 内科理论与实践, 2018, 13(05): 325-327.
[12]	何名扬, 孟兰霞, 肖宏,. 阿尔茨海默病和帕金森病朊蛋白样传播机制的研究进展[J]. 内科理论与实践, 2018, 13(05): 312-315.
[13]	崔海伦, 张一帆, 管晓军, 黄沛钰, 刘志蓉, 袁园, 刘晓云, 朱红灿, 曹学兵, 陈玲, 陈先文, 陈燕, 商慧芳, 杨任民, 陈生弟, 张敏鸣, 王刚,. 帕金森病及相关运动障碍的神经影像学诊断专家共识[J]. 内科理论与实践, 2018, 13(05): 320-324.
[14]	陈施吾, 王刚,. 帕金森病与肠道菌群关系的研究进展[J]. 内科理论与实践, 2018, 13(05): 316-319.
[15]	任汝静, 陈生弟, 王刚. 视频教学在运动障碍疾病诊断学教学中的应用思考[J]. 诊断学理论与实践, 2018, 17(04): 482-484.